Neville Rodie & Shaw Inc. Purchases 1,110 Shares of Intuitive Surgical, Inc. $ISRG

Key Points

• Neville Rodie & Shaw Inc. increased its stake in Intuitive Surgical, Inc. by 11.9% during Q2, now owning 10,427 shares valued at $5.67 million.
• Intuitive Surgical reported Q2 earnings of $2.19 EPS, exceeding analyst expectations of $1.93 EPS, with revenue reaching $2.44 billion.
• Insider selling activity includes EVP Myriam Curet offloading 4,500 shares for approximately $2.22 million, marking a 92.73% decrease in her position.

Neville Rodie & Shaw Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,427 shares of the medical equipment provider's stock after buying an additional 1,110 shares during the quarter. Neville Rodie & Shaw Inc.'s holdings in Intuitive Surgical were worth $5,666,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of ISRG. AlphaCore Capital LLC grew its position in Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider's stock worth $235,000 after acquiring an additional 18 shares during the last quarter. Second Line Capital LLC grew its position in Intuitive Surgical by 3.4% during the 4th quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider's stock worth $302,000 after acquiring an additional 19 shares during the last quarter. Crown Wealth Group LLC grew its position in Intuitive Surgical by 4.8% during the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after acquiring an additional 20 shares during the last quarter. FSM Wealth Advisors LLC grew its position in Intuitive Surgical by 3.8% during the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock worth $270,000 after acquiring an additional 20 shares during the last quarter. Finally, CFO4Life Group LLC grew its position in Intuitive Surgical by 4.8% during the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock worth $216,000 after acquiring an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amy L. Ladd sold 336 shares of the business's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $449.68 on Friday. The company has a market capitalization of $161.20 billion, a price-to-earnings ratio of 62.72, a P/E/G ratio of 4.78 and a beta of 1.61. The business's 50-day moving average is $485.67 and its 200-day moving average is $508.71. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm's revenue was up 21.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.78 EPS. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

Several research analysts have commented on the company. Evercore ISI lifted their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. BTIG Research lifted their target price on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Piper Sandler reaffirmed an "overweight" rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Zacks Research downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Thirteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.